Enterprise Financial Services Corp Teva Pharmaceutical Industries LTD Transaction History

Enterprise Financial Services Corp

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$8.61 - $11.04 $4,305 - $5,520	-500 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$8.57 - $12.69 $2,965 - $4,390	-346 Reduced 40.9%	500 $5,000
Q1 2020 May 15, 2020	BUY	$6.69 - $13.45 $3,345 - $6,725	500 Added 144.51%	846 $8,000
Q4 2019 Jan 28, 2020	SELL	$6.53 - $10.72 $653 - $1,072	-100 Reduced 22.42%	346 $3,000
Q2 2019 Jul 30, 2019	SELL	$8.12 - $15.72 $1,299 - $2,515	-160 Reduced 26.4%	446 $4,000
Q1 2019 Apr 26, 2019	BUY	$15.58 - $20.01 $93 - $120	6 Added 1.0%	606 $9,000
Q4 2018 Jan 25, 2019	SELL	$14.59 - $23.84 $817 - $1,335	-56 Reduced 8.54%	600 $9,000
Q2 2018 Jul 27, 2018	BUY	$16.77 - $24.71 $3,286 - $4,843	196 Added 42.61%	656 $16,000
Q4 2017 Jan 26, 2018	BUY	$11.23 - $19.1 $1,796 - $3,056	160 Added 53.33%	460 $9,000
Q3 2017 Oct 27, 2017	BUY	$15.41 - $32.17 $4,623 - $9,651	300	300 $5,000

625

573M

19.6M

6.77M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $24.5B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Enterprise Financial Services Corp, based on Form 13F filings with the SEC.

Stay updated on Enterprise Financial Services Corp with notifications on news.